India, Aug. 10 -- Bristol Myers Squibb (BMY) announced Monday an investment of approximately $2.3 billion in the U.S., while selecting Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus to accelerate the delivery of next-generation medicines to patients.
The approximately 600,000 square foot campus, at Generation Park in Houston, will create nearly 500 skilled, well-paying, long-term jobs initially and is designed to grow in scale, capability and workforce for decades to come.
The investment is part of the company's commitment to invest $40 billion in the United States over five years across research and development, technology and domestic manufacturing.
The Houston campus will be modular and multi-...